vs
Side-by-side financial comparison of AMERICAN SUPERCONDUCTOR CORP (AMSC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $74.5M, roughly 1.0× AMERICAN SUPERCONDUCTOR CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 21.4%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $2.4M). Over the past eight quarters, AMERICAN SUPERCONDUCTOR CORP's revenue compounded faster (33.2% CAGR vs 31.3%).
Anglo American plc is a British multinational mining company with headquarters in London, England. It is the world's largest producer of platinum, representing approximately 40 percent of global output, as well as being a major producer of diamonds, copper, nickel, iron ore, polyhalite and steelmaking coal. The company has operations in Africa, Asia, Australia, Europe, North America and South America.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
AMSC vs PBYI — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $74.5M | $75.5M |
| Net Profit | $117.8M | — |
| Gross Margin | 30.7% | 69.3% |
| Operating Margin | 4.5% | 22.7% |
| Net Margin | 158.1% | — |
| Revenue YoY | 21.4% | 27.7% |
| Net Profit YoY | 4679.1% | — |
| EPS (diluted) | $2.62 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $74.5M | $75.5M | ||
| Q3 25 | $65.9M | $54.5M | ||
| Q2 25 | $72.4M | $52.4M | ||
| Q1 25 | $66.7M | $46.0M | ||
| Q4 24 | $61.4M | $59.1M | ||
| Q3 24 | $54.5M | $80.5M | ||
| Q2 24 | $40.3M | $47.1M | ||
| Q1 24 | $42.0M | $43.8M |
| Q4 25 | $117.8M | — | ||
| Q3 25 | $4.8M | $8.8M | ||
| Q2 25 | $6.7M | $5.9M | ||
| Q1 25 | $1.2M | $3.0M | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $4.9M | $20.3M | ||
| Q2 24 | $-2.5M | $-4.5M | ||
| Q1 24 | $-1.6M | $-4.8M |
| Q4 25 | 30.7% | 69.3% | ||
| Q3 25 | 31.0% | 77.7% | ||
| Q2 25 | 33.8% | 76.5% | ||
| Q1 25 | 26.5% | 77.1% | ||
| Q4 24 | 26.6% | 76.4% | ||
| Q3 24 | 28.7% | 63.9% | ||
| Q2 24 | 30.3% | 77.4% | ||
| Q1 24 | 24.8% | 75.5% |
| Q4 25 | 4.5% | 22.7% | ||
| Q3 25 | 4.5% | 17.6% | ||
| Q2 25 | 7.8% | 12.7% | ||
| Q1 25 | 2.5% | 8.7% | ||
| Q4 24 | 2.1% | 22.6% | ||
| Q3 24 | -1.4% | 27.4% | ||
| Q2 24 | -8.2% | -4.6% | ||
| Q1 24 | -5.3% | -5.3% |
| Q4 25 | 158.1% | — | ||
| Q3 25 | 7.2% | 16.2% | ||
| Q2 25 | 9.3% | 11.2% | ||
| Q1 25 | 1.8% | 6.5% | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 9.0% | 25.2% | ||
| Q2 24 | -6.3% | -9.6% | ||
| Q1 24 | -3.8% | -11.0% |
| Q4 25 | $2.62 | $0.26 | ||
| Q3 25 | $0.11 | $0.17 | ||
| Q2 25 | $0.17 | $0.12 | ||
| Q1 25 | $0.04 | $0.06 | ||
| Q4 24 | $0.06 | $0.40 | ||
| Q3 24 | $0.13 | $0.41 | ||
| Q2 24 | $-0.07 | $-0.09 | ||
| Q1 24 | $-0.03 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $141.1M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $536.8M | $130.3M |
| Total Assets | $719.5M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.1M | $97.5M | ||
| Q3 25 | $212.9M | $94.4M | ||
| Q2 25 | $207.9M | $96.0M | ||
| Q1 25 | $79.5M | $93.2M | ||
| Q4 24 | $75.2M | $101.0M | ||
| Q3 24 | $72.1M | $96.7M | ||
| Q2 24 | $93.5M | $96.8M | ||
| Q1 24 | $90.5M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $536.8M | $130.3M | ||
| Q3 25 | $342.2M | $115.3M | ||
| Q2 25 | $333.1M | $104.7M | ||
| Q1 25 | $197.1M | $97.1M | ||
| Q4 24 | $192.7M | $92.1M | ||
| Q3 24 | $187.0M | $71.1M | ||
| Q2 24 | $143.3M | $48.5M | ||
| Q1 24 | $144.6M | $51.0M |
| Q4 25 | $719.5M | $216.3M | ||
| Q3 25 | $445.6M | $202.9M | ||
| Q2 25 | $452.8M | $194.9M | ||
| Q1 25 | $310.5M | $196.2M | ||
| Q4 24 | $310.3M | $213.3M | ||
| Q3 24 | $298.4M | $220.7M | ||
| Q2 24 | $240.1M | $205.0M | ||
| Q1 24 | $232.8M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.2M | $14.4M |
| Free Cash FlowOCF − Capex | $2.4M | $14.4M |
| FCF MarginFCF / Revenue | 3.2% | 19.1% |
| Capex IntensityCapex / Revenue | 1.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.03× | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.0M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | $14.4M | ||
| Q3 25 | $6.5M | $9.7M | ||
| Q2 25 | $4.1M | $14.1M | ||
| Q1 25 | $6.3M | $3.6M | ||
| Q4 24 | $5.9M | $15.6M | ||
| Q3 24 | $12.7M | $11.0M | ||
| Q2 24 | $3.4M | $1.0M | ||
| Q1 24 | $2.2M | $11.2M |
| Q4 25 | $2.4M | $14.4M | ||
| Q3 25 | $5.1M | $9.7M | ||
| Q2 25 | $3.3M | $14.1M | ||
| Q1 25 | $5.3M | $3.6M | ||
| Q4 24 | $5.3M | $15.6M | ||
| Q3 24 | $12.1M | $11.0M | ||
| Q2 24 | $3.1M | $1.0M | ||
| Q1 24 | $1.9M | — |
| Q4 25 | 3.2% | 19.1% | ||
| Q3 25 | 7.7% | 17.7% | ||
| Q2 25 | 4.6% | 26.8% | ||
| Q1 25 | 7.9% | 7.7% | ||
| Q4 24 | 8.7% | 26.4% | ||
| Q3 24 | 22.3% | 13.7% | ||
| Q2 24 | 7.8% | 2.1% | ||
| Q1 24 | 4.6% | — |
| Q4 25 | 1.2% | 0.0% | ||
| Q3 25 | 2.1% | 0.0% | ||
| Q2 25 | 1.1% | 0.0% | ||
| Q1 25 | 1.6% | 0.1% | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 1.1% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.7% | 0.0% |
| Q4 25 | 0.03× | — | ||
| Q3 25 | 1.37× | 1.10× | ||
| Q2 25 | 0.61× | 2.41× | ||
| Q1 25 | 5.22× | 1.21× | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.60× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
PBYI
Segment breakdown not available.
